Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Türkiye
Türkiye: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.0% in 2024. ▼ Falling
Latest (2024)
0.0%
World rank
168th
of 247 countries
All-time high
0.1%
in 2015
All-time low
0.0%
in 2023
Years of data
10
2015–2024
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Türkiye, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Türkiye recorded 0.0% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 100.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Türkiye peaked at 0.1% in 2015 and was at its lowest, 0.0%, in 2023.
Türkiye ranks 168th of 247 countries on this measure, in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Türkiye, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.1% | — |
| 2016 | 0.1% | +0.0% |
| 2017 | 0.1% | +0.0% |
| 2018 | 0.1% | +0.0% |
| 2019 | 0.1% | +0.0% |
| 2020 | 0.1% | +0.0% |
| 2021 | 0.1% | +0.0% |
| 2022 | 0.1% | +0.0% |
| 2023 | 0.0% | -100.0% |
| 2024 | 0.0% | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.1% | 5 |
| 2020s | 0.1% | 0.0% | 0.1% | 5 |
Countries ranked near Türkiye
- 168 Andorra 0.0%
- 168 Argentina 0.0%
- 168 Austria 0.0%
- 168 Bahrain 0.0%
- 168 Belarus 0.0%
- 168 Belgium 0.0%
- 168 Bermuda 0.0%
- 168 Brazil 0.0%
- 168 Bulgaria 0.0% compare
- 168 Canada 0.0%
- 168 Chile 0.0%
- 168 Colombia 0.0%
- 168 Cook Islands 0.0%
- 168 Costa Rica 0.0%
- 168 Croatia 0.0%
- 168 Cuba 0.0%
- 168 Czechia 0.0%
- 168 Ecuador 0.0%
- 168 Egypt 0.0% compare
- 168 El Salvador 0.0%
- 168 Estonia 0.0%
- 168 Falkland Islands (Malvinas) 0.0%
- 168 Faroe Islands 0.0% compare
- 168 Finland 0.0%
- 168 France 0.0%
- 168 French Guiana 0.0%
- 168 French Polynesia 0.0% compare
- 168 Georgia 0.0%
- 168 Germany 0.0%
- 168 Gibraltar 0.0%
- 168 Greece 0.0%
- 168 Greenland 0.0%
- 168 Guatemala 0.0% compare
- 168 Guernsey 0.0% compare
- 168 Holy See 0.0%
- 168 Honduras 0.0%
- 168 Iceland 0.0% compare
- 168 Iran (Islamic Republic of) 0.0%
- 168 Ireland 0.0%
- 168 Isle of Man 0.0% compare
- 168 Italy 0.0%
- 168 Japan 0.0% compare
- 168 Jersey 0.0% compare
- 168 Kuwait 0.0%
- 168 Latvia 0.0% compare
- 168 Liechtenstein 0.0%
- 168 Luxembourg 0.0%
- 168 Malta 0.0% compare
- 168 Mexico 0.0%
- 168 Monaco 0.0%
- 168 Montenegro 0.0%
- 168 Morocco 0.0%
- 168 Netherlands (Kingdom of the) 0.0%
- 168 New Zealand 0.0% compare
- 168 Nicaragua 0.0% compare
- 168 Niue 0.0%
- 168 Norway 0.0% compare
- 168 Panama 0.0%
- 168 Poland 0.0%
- 168 Portugal 0.0%
- 168 Qatar 0.0% compare
- 168 Republic of Korea 0.0% compare
- 168 Saint Pierre and Miquelon 0.0%
- 168 San Marino 0.0%
- 168 Saudi Arabia 0.0%
- 168 Slovakia 0.0%
- 168 Slovenia 0.0% compare
- 168 Spain 0.0%
- 168 State of Palestine 0.0% compare
- 168 Sweden 0.0%
- 168 Switzerland 0.0% compare
- 168 Tokelau 0.0%
- 168 United Arab Emirates 0.0%
- 168 United Kingdom of Great Britain and Northern Ireland 0.0% compare
- 168 Uruguay 0.0%
- 168 South Korea 0.0% compare
- 168 Turkey 0.0% compare
- 168 United Kingdom 0.0% compare
- 168 United States 0.0%
More development goals data for Türkiye
- Red List Index 0.8224 (2025)
- Number of refugees per 100,000 population, by country of origin 165.31 (2025)
- Manufacturing value added per capita 2,060 (2025)
- Number of transboundary breeds 24 (2025)
- Number of transboundary breeds (not extinct) 20 (2025)
- Number of transboundary breeds with unknown risk status 6 (2025)
- Number of local breeds with unknown risk status 29 (2025)
- Number of local breeds (not extinct) 82 (2025)
- Number of local breeds kept in the country 113 (2025)
- Infant deaths 8,552 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Türkiye?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Türkiye was 0.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Türkiye?
- The highest recorded value was 0.1% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Türkiye?
- The lowest recorded value was 0.0% in 2023.
- How does Türkiye rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Türkiye ranks 168th out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Türkiye?
- Over the last ten years it is down 100.0%. The long-run trend across the full record is falling.
- Where does this Türkiye data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).